| content | ||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
Dibekacin
|
|
| Systematic (IUPAC) name | |
| (2S,3R,4S,5S,6R)-4-Amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol | |
| Identifiers | |
| CAS number | ? |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C18H37N5O8 |
| Mol. mass | 451.52 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Dibekacin is an aminoglycoside antibiotic.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||
